Big Pharma News Today in India-Eli Lilly: The Company Secures Groundbreaking CDSCO Approval for Its Alzheimer’s Drug, Donanemab
Every day, headlines under big pharma news today in India talk about breakthroughs that could reshape the future of healthcare. One such major development is the approval of Eli Lilly’s Alzheimer’s drug, Donanemab, by the CDSCO. Alzheimer’s disease remains a global crisis—progressive, debilitating, and emotionally overwhelming for families. Understanding the Global Burden One of the … Read more